SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001740053-19-000004
Filing Date
2019-08-23
Accepted
2019-08-23 13:41:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 DVAX 13G 08232019 dvax.txt SC 13G 5938
  Complete submission text file 0001740053-19-000004.txt   7440
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80035 | Film No.: 191048409
SIC: 2834 Pharmaceutical Preparations

Mailing Address 135 S LASALLE ST SUITE 3450 CHICAGO IL 60603
Business Address 135 S LASALLE ST SUITE 3450 CHICAGO IL 60603 3124292335
Chicago Capital, LLC (Filed by) CIK: 0001740053 (see all company filings)

IRS No.: 823400556 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G